Increased NF-κB activity is associated with TMZ-resistance in glioma64, radioresistance of glioblastoma stem cells41, and inhibition of NF-κB activity in combination with temozolomide significantly improved glioma treatment outcome65. Here, NFKB1 is linked to central nervous system cancer.